Biopharmaceutical company
Implementation of Home Infusion Therapy Benefit in Medicare CY 2021 Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Policy Issues and Healthcare Common Procedure Coding System (HCPCS) Level II Proposed Rule (CMS-1738-P) and Durable Medical Equipment Fee Schedule Adjustments To Resume the Transitional 50/50 Blended Rates to Provide Relief in Rural Areas and Non-Contiguous Areas; Extension of Timeline for Final Rule Publication (CMS-1687-RCN). Provisions included in Subtitle J of H.R. 5376 - Build Back Better Act and Senate reconciliation bill. Issues related to access and coverage in Medicare Part D program. Inclusion of study on genetically targeted technologies in S. 4348 - FDASLA Act of 2022 and H.R. 7667 - Food and Drug Amendments of 2022.
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
JOHN MCMANUS (Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas) ALANNA TEMME (LD, Rep. Jon Porter) JOHN MCMANUS ALANNA TEMME
Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas LD, Rep. Jon Porter